-
公开(公告)号:US20240228629A1
公开(公告)日:2024-07-11
申请号:US18277218
申请日:2022-01-14
申请人: City of Hope
发明人: Alfur Hung , Miso Park , Yi-Chiu Kuo , John C. Williams
CPC分类号: C07K16/2863 , A61P35/00 , A61K2039/505 , C07K2317/565
摘要: Provided herein are, inter alia, novel antibodies that specifically bind to domain IV of EGFR and are able to effectively induce antibody dependent cell mediated cytoxicity (ADCC) against EGFR-expressing cells. In embodiments, the immunoglobulin and the Fab of the antibodies provided herein bind domain IV of EGFR with differential affinity. Thus, the antibodies provided herein provide for highly specific antibody therapeutics without adverse effects.
-
公开(公告)号:US11279752B2
公开(公告)日:2022-03-22
申请号:US16559561
申请日:2019-09-03
发明人: John C. Williams , Ulrich Rodeck , Kurt Jenkins
摘要: Provided herein are recombinant masking proteins and recombinant ligand proteins useful in treating cancer, neurodegenerative disease, and cardiovascular disease. The recombinant masking proteins provided herein may, inter alia, be used as non-covalent masks of antagonists of, for example, cellular growth factors (e.g., TNF) or cell surface proteins (e.g., CTLA-4).
-
公开(公告)号:US20200164077A1
公开(公告)日:2020-05-28
申请号:US16460957
申请日:2019-07-02
申请人: CITY OF HOPE
发明人: John C. Williams , Cindy Zer , Kendra N. Avery , Ulrich Rodeck , Joshua M. Donaldson , Csaba Kari
摘要: In one embodiment, a masked monoclonal antibody (mAb) is provided, the mAb, encoded by a nucleic acid sequence or an amino acid sequence molecule comprising a signal sequence, a masking epitope sequence, a linker sequence that is cleavable by a protease specific to a target tissue; and an antibody or a functional fragment thereof. In another embodiment, a masked monoclonal antibody (mAb) is provided, which includes a therapeutic mAb and a mask, the mask comprising protein A and protein L attached by a protease cleavable linker.
-
公开(公告)号:US09260710B2
公开(公告)日:2016-02-16
申请号:US14754064
申请日:2015-06-29
申请人: City of Hope
发明人: John C. Williams , David Horne , Jun Xie , Shubbir Ahmed
IPC分类号: C12N9/96 , C12N9/90 , C07D211/60 , G01N33/50
CPC分类号: C12N9/90 , C07D211/60 , C12N9/93 , C12N9/96 , C12Y502/01 , C12Y502/01008 , G01N33/5023 , G01N2333/4703 , G01N2333/914
摘要: There are provided, inter alia, photolabile compounds and methods useful for the formation of dimers of biological molecules and subsequent dissociation of the dimers.
-
公开(公告)号:US12060435B2
公开(公告)日:2024-08-13
申请号:US16959981
申请日:2019-01-07
申请人: CITY OF HOPE
发明人: John C. Williams , Jeremy King
CPC分类号: C07K16/32 , A61K47/65 , A61P35/00 , C07K16/2803 , C07K16/2809 , C07K16/283 , C07K16/2866 , C07K16/2875 , C07K16/2878 , C07K16/2887 , C07K16/3092 , C12N5/0636 , C07K2317/31 , C07K2317/51 , C07K2317/515 , C07K2317/52 , C07K2317/524 , C07K2317/526 , C07K2317/55 , C07K2317/569 , C07K2317/64
摘要: Provided herein are, inter alia, novel peptide compositions having multi-specific binding capabilities useful for therapeutic and diagnostic purposes. The peptide compositions provided herein are polypeptide conjugates including at least two ligand binding domains able to target (bind) two or more ligands (e.g., antigens) at the same time. The peptide compositions provided herein can be produced at very high yields and are therefore easy to manufacture.
-
公开(公告)号:US11246942B2
公开(公告)日:2022-02-15
申请号:US15614468
申请日:2017-06-05
申请人: City of Hope
发明人: John C. Williams , David A. Horne , Yuelong Ma , Heng Wei Chang , Joshua Michael Donaldson , Cindy Zer , Krzysztof Bzymek , Kendra Nicole Avery , Jun Xie
IPC分类号: C07K16/18 , C07K16/28 , C07K16/32 , A61K38/08 , A61K39/395 , A61K47/06 , A61K51/10 , B82Y5/00 , A61K38/12 , A61K47/68 , A61K47/66
摘要: Antibodies and meditopes that bind to the antibodies are provided, as well as complexes, compositions and combinations containing the meditopes and antibodies, and methods of producing, using, testing, and screening the same, including therapeutic and diagnostic methods and uses.
-
公开(公告)号:US10414814B2
公开(公告)日:2019-09-17
申请号:US15322438
申请日:2015-07-02
发明人: John C. Williams , Ulrich Rodeck , Kurt Jenkins
IPC分类号: C07K14/82 , C07K16/46 , C07K14/705 , C12N9/64 , C07K14/435 , C07K19/00 , C07K16/28 , C07K14/47 , C07K14/71
摘要: Provided herein are recombinant masking proteins and recombinant ligand proteins useful in treating cancer, neurodegenerative disease, and cardiovascular disease. The recombinant masking proteins provided herein may, inter alia, be used as non-covalent masks of antagonists of, for example, cellular growth factors (e.g., TNF) or cell surface proteins (e.g., CTLA-4).
-
公开(公告)号:US09574014B2
公开(公告)日:2017-02-21
申请号:US15156159
申请日:2016-05-16
申请人: City of Hope
发明人: John C. Williams , Christine Brown
IPC分类号: C07K16/40 , C07K14/705 , C07K14/725
CPC分类号: C07K16/40 , C07K14/7051 , C07K14/70521 , C07K16/32 , C07K2317/24 , C07K2317/622 , C07K2318/20 , C07K2319/03 , C07K2319/70
摘要: Provided herein are compositions which exhibit novel diagnostic capabilities and allow to rapidly add functionality to adoptive immunotherapy. The compositions include isolated nucleic acids encoding proteins including antibody regions capable of binding compounds including a peptidyl moiety (e.g., a meditope). The recombinant proteins provided herein are useful, inter alia, for a broad variety of therapeutic and diagnostic purposes. For example, the recombinant proteins provided herein including embodiments thereof may be used as non-invasive means to characterize chimeric antigen receptor (CAR) T cells before and/or during treatment of diseases (e.g., cancer).
摘要翻译: 本文提供了表现出新的诊断能力并允许快速添加过继性免疫治疗功能的组合物。 组合物包括编码蛋白质的分离的核酸,包括能够结合化合物的抗体区域,所述化合物包括肽基部分(例如,中间体)。 本文提供的重组蛋白尤其可用于多种治疗和诊断目的。 例如,本文提供的重组蛋白质包括其实施方案可以用作在疾病(例如癌症)治疗之前和/或期间表征嵌合抗原受体(CAR)T细胞的非侵入性手段。
-
公开(公告)号:US20220073613A1
公开(公告)日:2022-03-10
申请号:US17417239
申请日:2019-12-26
发明人: John C. Williams , Margaret Karow
摘要: The invention provides activatable masked anti-CTLA4 binding proteins (e.g., antibodies, bispecific antibodies, and chimeric receptors) and their use in treating and preventing cancer, as well as compositions and kits comprising the activatable masked anti-CTLA4 binding proteins.
-
公开(公告)号:US20170226223A1
公开(公告)日:2017-08-10
申请号:US15433939
申请日:2017-02-15
申请人: City of Hope
发明人: John C. Williams , Christine Brown
IPC分类号: C07K16/32 , C07K14/705 , C07K14/725
CPC分类号: C07K16/32 , C07K14/7051 , C07K14/70517 , C07K14/70521 , C07K14/70575 , C07K16/40 , C07K2317/24 , C07K2317/53 , C07K2317/55 , C07K2317/622 , C07K2317/73 , C07K2318/20 , C07K2319/03 , C07K2319/70
摘要: Provided herein are compositions which exhibit novel diagnostic capabilities and allow to rapidly add functionality to adoptive immunotherapy. The compositions include isolated nucleic acids encoding proteins including antibody regions capable of binding compounds including a peptidyl moiety (e.g., a meditope). The recombinant proteins provided herein are useful, inter alia, for a broad variety of therapeutic and diagnostic purposes. For example, the recombinant proteins provided herein including embodiments thereof may be used as non-invasive means to characterize chimeric antigen receptor (CAR) T cells before and/or during treatment of diseases (e.g., cancer).
-
-
-
-
-
-
-
-
-